Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Orlistat in Type I Hyperlipoproteinemia
NCT02767531Phase 2Completed
- Sponsor
- UT Southwestern Medical Center
- Start
- Dec 2015
- Primary completion
- May 2018
- Countries
- 1
01
Overview
A Phase 2 trial of orlistat in familial lipoprotein lipase deficiency (LPLD), hypertriglyceridemia, sponsored by UT Southwestern Medical Center. Started Dec 2015; status: completed.
02
Drugs
orlistat
03
Conditions
familial lipoprotein lipase deficiency (LPLD)hypertriglyceridemia
Beyond the preview
Go deeper on NCT02767531.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02767531.